Dr. Robert Gerstenbluth , MD
Urology • Schenectady, NY
2200 Rosa Rd
Schenectady, NY 123093717
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 4, 2006; this date does not establish years in practice.
-
Published CMS data list 919 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 358 service units.
- 99214 — Established patient outpatient office visit: 187 service units.
- 52000 — Diagnostic exam of bladder and urethra using an endoscope: 97 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 17 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,753 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 686 prescription fills, including refills.
- Finasteride — 621 prescription fills, including refills.
- Cephalexin — 228 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 29 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Urology in New York (2024, 677 clinicians with data). Median for this group: 1,005. Middle half: 436 to 3,529.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,131 in 2020 to 919 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
2200 Rosa Rd
Schenectady, NY 123093717
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Ellis Hospital. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2006
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
479 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $78,597 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $57,831 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
6,491 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$813,693 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,981.44 across 68 records.
By nature of payment
- Food and Beverage: $1,889.24 across 67 records.
- Education: $92.20 across 1 record.
Reporting-company totals (3 largest of 18)
- Janssen Pharmaceuticals, Inc: $398.68 across 11 records.
- Astellas Pharma US Inc: $368.01 across 8 records.
- Ferring Pharmaceuticals Inc.: $242.77 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
20 years (graduated 2006)
CMS Doctors and Clinicians data list 2006 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Gerstenbluth has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Gerstenbluth as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Schenectady and New York
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Urology in New York (2024, 677 clinicians with data). Median for this group: 1,005. Middle half: 436 to 3,529.
Too few clinicians listed under Urology in Schenectady have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
Close to the middle for clinicians listed under Urology in New York (2024, 677 clinicians with data). Median for this group: $101,180. Middle half: $38,168 to $249,781.
Too few clinicians listed under Urology in Schenectady have Medicare Part B data for 2024 to compare.
Paid by Medicare
Close to the middle for clinicians listed under Urology in New York (2024, 677 clinicians with data). Median for this group: $75,481. Middle half: $28,363 to $187,263.
Too few clinicians listed under Urology in Schenectady have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Urology in New York (2024, 745 clinicians with data). Median for this group: 913. Middle half: 216 to 1,942.
Too few clinicians listed under Urology in Schenectady have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Urology in New York (2024, 745 clinicians with data). Median for this group: $79,790. Middle half: $12,830 to $271,371.
Too few clinicians listed under Urology in Schenectady have Medicare Part D data for 2024 to compare.
4 active clinicians are listed under Urology with a practice address in Schenectady, NY (1,091 in New York).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 71% from 3,131 in 2020 to 919 in 2024.
- 2020: 3,131
- 2021: 3,193
- 2022: 2,074
- 2023: 975
- 2024: 919
-
Medicare-allowed amount
Medicare-allowed amount decreased 68% from $243,537 in 2020 to $78,597 in 2024.
- 2020: $243,537
- 2021: $273,143
- 2022: $176,782
- 2023: $85,555
- 2024: $78,597
-
Paid by Medicare
Paid by Medicare decreased 68% from $181,749 in 2020 to $57,831 in 2024.
- 2020: $181,749
- 2021: $205,721
- 2022: $127,536
- 2023: $63,031
- 2024: $57,831
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 2,706 in 2020 and 2,753 in 2024.
- 2020: 2,706
- 2021: 2,739
- 2022: 2,823
- 2023: 2,423
- 2024: 2,753
-
30-day fills
30-day fills stayed about the same: 6,901 in 2020 and 6,491 in 2024.
- 2020: 6,901
- 2021: 7,033
- 2022: 7,087
- 2023: 5,715
- 2024: 6,491
-
Part D drug cost
Part D drug cost decreased 20% from $1,018,182 in 2020 to $813,693 in 2024.
- 2020: $1,018,182
- 2021: $818,821
- 2022: $1,137,901
- 2023: $1,009,747
- 2024: $813,693
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $258.89 in 2021 to $1,981.44 in 2025.
- 2021: $258.89
- 2022: $667.21
- 2023: $476.90
- 2024: $1,002.52
- 2025: $1,981.44
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 68 records totaling $1,981.44.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $121.84 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $113.10 |
| COLOPLAST CORP |
Food and Beverage
In-kind items and services
|
Luja Coude | General | $100.40 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
— | General | $92.20 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $41.74 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $41.22 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
BARRIGEL | General | $40.56 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $33.04 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $33.04 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $32.35 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $31.10 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $30.93 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $29.78 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $29.50 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $29.07 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $28.91 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $28.79 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $28.54 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
— | General | $28.27 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $28.09 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $27.56 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $26.96 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $26.95 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $26.86 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $26.78 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
358 | 288 | $156.85 | $62.82 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
187 | 149 | $235.61 | $93.49 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
97 | 85 | $362.00 | $76.43 |
|
76000
Imaging guidance for procedure, 60 minutes or less
|
33 | 28 | $39.00 | $14.17 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
30 | 30 | $386.00 | $127.50 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
30 | 27 | $407.00 | $125.42 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
23 | 22 | $601.00 | $166.20 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
20 | 13 | $216.00 | $75.91 |
|
55700
Biopsy of prostate gland
|
19 | 19 | $916.89 | $119.01 |
|
52332
Insertion of stent in ureter using an endoscope
|
17 | 12 | $469.00 | $116.12 |
|
76942
Ultrasonic guidance for needle placement
|
17 | 17 | $101.00 | $28.99 |
|
52310
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope
|
16 | 16 | $457.00 | $143.59 |
|
52356
Crushing of stone of ureter with insertion of stent using an endoscope
|
16 | 16 | $1159.00 | $392.67 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
16 | 16 | $228.00 | $78.40 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
16 | 16 | $355.88 | $132.19 |
|
51703
Complicated insertion of bladder tube
|
12 | 11 | $233.00 | $72.39 |
|
76857
Limited ultrasound scan of pelvis
|
12 | 12 | $76.00 | $22.43 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 686 | 59,107 | $11,275.95 | 232 |
| Finasteride | Finasteride | 621 | 54,509 | $9,919.45 | 204 |
| Cephalexin | Cephalexin | 228 | 3,739 | $1,411.12 | 179 |
| Myrbetriq | Mirabegron | 162 | 11,251 | $164,127.95 | 57 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 160 | 12,296 | $5,504.08 | 56 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 97 | 440 | $534.67 | 85 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 89 | 7,690 | $2,181.06 | 25 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 70 | 181 | $296.28 | 61 |
| Dutasteride | Dutasteride | 65 | 5,614 | $1,706.99 | 19 |
| Potassium Citrate Er | Potassium Citrate | 61 | 4,252 | $8,447.46 | 16 |
| Levofloxacin | Levofloxacin | 57 | 476 | $379.90 | 38 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 57 | 2,777 | $263.74 | 37 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 52 | 4,440 | $2,233.40 | 22 |
| Testosterone Cypionate | Testosterone Cypionate | 42 | 1,994 | $1,982.58 | 11 |
| Prednisone | Prednisone | 35 | 521 | $53.83 | — |
| Testosterone | Testosterone | 30 | 1,335 | $7,305.69 | — |
| Estradiol | Estradiol | 27 | 1,791 | $1,708.18 | 14 |
| Gemtesa | Vibegron | 24 | 1,620 | $24,324.12 | — |
| Xtandi | Enzalutamide | 23 | 690 | $311,606.45 | — |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 22 | 126 | $145.11 | 16 |
| Bicalutamide | Bicalutamide | 22 | 1,155 | $439.74 | 15 |
| Mirabegron Er | Mirabegron | 22 | 1,620 | $14,735.72 | — |
| Erleada | Apalutamide | 17 | 510 | $204,874.41 | — |
| Sildenafil Citrate | Sildenafil Citrate | 16 | 850 | $58.27 | — |
| Solifenacin Succinate | Solifenacin Succinate | 16 | 1,440 | $477.93 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20040814000156
NY
5698748010
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Ellis Hospital
1201 Nott St, Schenectady, NY 123082589
Phone: 5182434000
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Nurse Practitioner - Family
Family Nurse Practitioner
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated July 04, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Schenectady
Healthcare providers in SchenectadyMailing Address
208 Connor Ct
Niskayuna, NY 123093523
Phone: 5183811848